Munafa Stock Market Course + Intraday & FNO calls 
Nektar Therapeutics (NKTR) Technical (Analysis) Reports Nektar Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Nektar Therapeutics (NKTR)
Technical Analysis Report for USA stock NKTR Nektar Therapeutics. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NKTR Nektar Therapeutics then click here. or read Experts views on Nektar Therapeutics or Forecast & share price targets of Nektar Therapeutics
Nektar Therapeutics Opened at 43.50 and Closed at: 42.22, which is -3.22% of previous session's close. It moved within a range of 41.35 and 43.50
The session was a Bearish session with an average volume of 2029300, which is -44.06% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
A Dead cross was found 3 days back on long term averages
Support for tomorrow is 40.71 and resistance for tomorrow is 42.86
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 41.21, 40.21 resistance for tomorrow's hourly charts is 43.36, 44.51
10 Day SMA for Nektar Therapeutics (NKTR) is 54.8 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Nektar Therapeutics (NKTR) is 62.1 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Nektar Therapeutics (NKTR) is 68.91 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 67.31 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Nektar Therapeutics is 65.56 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Nektar Therapeutics is at 62.1 and 200 DMA is at 65.56, while 50 DMA and 100 DMA are at 68.91 and 67.31 respectively
Nektar Therapeutics (NKTR) moving average of 20 SMA is at 62.1 and 20 EMA is at 59.49
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 42.22 | 62.1 | 59.49 |
| 02 Fri Oct | 43.58 | 63.7 | 61.31 |
| 01 Thu Oct | 47.00 | 65.33 | 63.18 |
| 30 Wed Sep | 60.55 | 66.62 | 64.88 |
| 29 Tue Sep | 59.24 | 67.18 | 65.34 |
| 28 Mon Sep | 60.40 | 67.79 | 65.98 |
Nektar Therapeutics (NKTR) moving average of 50 SMA is at 68.91 and 50 EMA is at 65.49
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 42.22 | 68.91 | 65.49 |
| 02 Fri Oct | 43.58 | 69.48 | 66.44 |
| 01 Thu Oct | 47.00 | 70.02 | 67.37 |
| 30 Wed Sep | 60.55 | 70.47 | 68.2 |
| 29 Tue Sep | 59.24 | 70.64 | 68.51 |
| 28 Mon Sep | 60.40 | 70.83 | 68.89 |
Nektar Therapeutics (NKTR) moving average of 100 SMA is at 67.31 and 100 EMA is at 67.17
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 42.22 | 67.31 | 67.17 |
| 02 Fri Oct | 43.58 | 67.65 | 67.67 |
| 01 Thu Oct | 47.00 | 68 | 68.16 |
| 30 Wed Sep | 60.55 | 68.31 | 68.59 |
| 29 Tue Sep | 59.24 | 68.53 | 68.75 |
| 28 Mon Sep | 60.40 | 68.77 | 68.94 |
Nektar Therapeutics (NKTR) moving average of 200 SMA is at 65.56 and 200 EMA is at 62.31
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 42.22 | 65.56 | 62.31 |
| 02 Fri Oct | 43.58 | 65.58 | 62.51 |
| 01 Thu Oct | 47.00 | 65.6 | 62.7 |
| 30 Wed Sep | 60.55 | 65.63 | 62.86 |
| 29 Tue Sep | 59.24 | 65.61 | 62.88 |
| 28 Mon Sep | 60.40 | 65.56 | 62.92 |
Zimmer Biomet has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Zimmer Biomet, about 41.22% more returns!
Teleflex Incorporated has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 35.45% more returns!
Novo Nordisk has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Novo Nordisk, about 27.2% more returns!
Iqvia Holdings has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Iqvia Holdings, about 46.68% more returns!
Globus Medical has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Globus Medical, about 46.07% more returns!
Boston Scientific has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Boston Scientific, about 38.36% more returns!
Bristol Myers has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Bristol Myers, about 34.94% more returns!
Veru Inc has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Veru Inc, about 42.87% more returns!
Nature S has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Nature S, about 33.76% more returns!
Lemaitre Vascular has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Lemaitre Vascular, about 45.79% more returns!
Ionis Pharmaceuticals has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 20.84% more returns!
Inmune Bio has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 21.32% more returns!
Icu Medical has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Icu Medical, about 44.35% more returns!
Denali Therapeutics has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Denali Therapeutics, about 34.2% more returns!
Atara Biotherapeutics has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Atara Biotherapeutics, about 35.92% more returns!
Anaptysbio Inc has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Anaptysbio Inc, about 30.96% more returns!
Addus Homecare has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Addus Homecare, about 38.72% more returns!
Acadia Pharmaceuticals has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 16.95% more returns!
Nektar Therapeutics Technical analysis of indicators
Price action analysis of Nektar Therapeutics (NKTR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Nektar Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Nektar Therapeutics in short term and the sell signal is strong.
Nektar Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Nektar Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Nektar Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 53.33 and Nektar Therapeutics NKTR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Nektar Therapeutics NKTR stock. Volume based technical analysis of Nektar Therapeutics NKTR stock is negative.
Nektar Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NKTR Nektar Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NKTR Experts View which covers a lot of information including buying and selling signals
NKTR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Nektar Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Nektar Therapeutics (NKTR) Technical (Analysis) Reports Nektar Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
